Jiangsu Lianhuan Pharmaceutical Group Co., Ltd. produces products.

Jiangsu Lianhuan Pharmaceutical Group has the production capacity and import and export rights of hundreds of varieties in four categories, including chemical synthetic drugs, antibiotics, various preparations and pharmaceutical excipients, and its annual foreign exchange earnings reach more than 30 million US dollars. All the existing preparations and APIs have passed the national GMP certification inspection. Six API products, such as doxycycline hydrochloride and hydrocortisone, have passed the inspection and approval of FDA, and doxycycline hydrochloride has obtained COS certificate issued by EDQM in Europe. More than 20 kinds of products are exported to more than 30 countries and regions such as the United States, Canada, Britain, France, Germany, Australia and India. The production of norethindrone and levonorgestrel, female contraceptives, accounts for more than 50% of the total national output. They have been invited by the United Nations Population Fund for many years and designated by the National Family Planning Commission. Terfenadine, cetirizine hydrochloride, ebastine and other antihistamines form an echelon. Felodipine, simvastatin, lumbrokinase and other cardiovascular drugs form a series. The group has become a well-known production base of steroid hormones, antihistamines and cardiovascular drugs in the whole province and even the whole country.